In light of Republic Act No. 11467, the Consolidated VAT Regulations of 2005 (RR No. 16-2005, as amended by RR No. 13-2018) have been amended to include the VAT-exempt sale or importation of prescription drugs and medicines for:
- Diabetes, high cholesterol and hypertension (beginning 1 January 2020); and
- Cancer, mental illness, tuberculosis and kidney disease (beginning 1 January 2023).
Source PwC
Latest Posts in "Philippines"
- VAT Reduction to 10% Risks Fiscal Deficit, Benefits Wealthy, Warns Philippine Finance Department
- BIR Collects P2.8B from Digital Services VAT, Exceeds Compliance Expectations with 371 DSPs Registered
- BIR Falls Short of VAT Collection Target by P6.37 Billion in First Seven Months
- Philippine Court Clarifies Input VAT Refunds for Zero-Rated Sales in Electricity Sector Case
- Philippine Court Clarifies Input VAT Refunds for Zero-Rated Sales in Automotive Export Case
